| Year |
Citation |
Score |
| 2024 |
Clark J, Hoxie I, Adelsberg DC, Sapse IA, Andreata-Santos R, Yong JS, Amanat F, Tcheou J, Raskin A, Singh G, González-Domínguez I, Edgar JE, Bournazos S, Sun W, Carreño JM, ... ... Ellebedy AH, et al. Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination. Biorxiv : the Preprint Server For Biology. PMID 38464151 DOI: 10.1101/2024.02.28.582613 |
0.437 |
|
| 2024 |
Boon J, Soudani N, Bricker T, Darling T, Seehra K, Patel N, Guebre-Xabier M, Smith G, Suthar M, Ellebedy A, Davis-Gardner M. Immunogenicity and efficacy of XBB.1.5 rS vaccine against EG.5.1 variant of SARS-CoV-2 in Syrian hamsters. Research Square. PMID 38405749 DOI: 10.21203/rs.3.rs-3873514/v1 |
0.566 |
|
| 2024 |
Zimmerman O, Altman Doss AM, Ying B, Liang CY, Mackin SR, Davis-Adams HG, Adams LJ, VanBlargan LA, Chen RE, Scheaffer SM, Desai P, Raju S, Mantia TL, O'Shaughnessy CC, Monroy JM, ... ... Ellebedy AH, et al. Immunoglobulin replacement products confer in vivo protection against SARS-CoV-2 XBB.1.5 Omicron variant despite poor neutralizing activity. Jci Insight. PMID 38175703 DOI: 10.1172/jci.insight.176359 |
0.407 |
|
| 2023 |
Wu NC, Ellebedy AH. Targeting neuraminidase: the next frontier for broadly protective influenza vaccines. Trends in Immunology. PMID 38103991 DOI: 10.1016/j.it.2023.11.001 |
0.628 |
|
| 2023 |
Lei R, Kim W, Lv H, Mou Z, Scherm MJ, Schmitz AJ, Turner JS, Tan TJC, Wang Y, Ouyang WO, Liang W, Rivera-Cardona J, Teo C, Graham CS, Brooke CB, ... ... Ellebedy AH, et al. Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase. Immunity. 56: 2621-2634.e6. PMID 37967533 DOI: 10.1016/j.immuni.2023.10.005 |
0.565 |
|
| 2023 |
Rijnink WF, Stadlbauer D, Puente-Massaguer E, Okba NMA, Kirkpatrick Roubidoux E, Strohmeier S, Mudd PA, Schmitz A, Ellebedy A, McMahon M, Krammer F. Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses. Journal of Virology. e0164622. PMID 37916834 DOI: 10.1128/jvi.01646-22 |
0.651 |
|
| 2023 |
Krammer F, Ellebedy AH. Variant-adapted COVID-19 booster vaccines. Science (New York, N.Y.). 382: 157-159. PMID 37824671 DOI: 10.1126/science.adh2712 |
0.474 |
|
| 2023 |
Mudd P, Borcherding N, Kim W, Quinn M, Han F, Zhou J, Sturtz A, Schmitz A, Lei T, Schattgen S, Klebert M, Suessen T, Middleton W, Goss C, Liu C, ... ... Ellebedy A, et al. Antigen-specific CD4 T cells exhibit distinct transcriptional phenotypes in the lymph node and blood following vaccination in humans. Research Square. PMID 37790414 DOI: 10.21203/rs.3.rs-3304466/v1 |
0.334 |
|
| 2023 |
Schattgen SA, Turner JS, Ghonim MA, Crawford JC, Schmitz AJ, Kim H, Zhou JQ, Awad W, Kim W, McIntire KM, Haile A, Klebert MK, Suessen T, Middleton WD, Teefey SA, ... ... Ellebedy AH, et al. Spatiotemporal development of the human T follicular helper cell response to Influenza vaccination. Biorxiv : the Preprint Server For Biology. PMID 37693531 DOI: 10.1101/2023.08.29.555186 |
0.526 |
|
| 2023 |
Hultgren S, Timm M, Tamadonfar K, Nye T, Pinkner J, Dodson K, Ellebedy A. Vaccination with Acinetobacter baumannii adhesin Abp2D provides protection against catheter-associated urinary tract infection. Research Square. PMID 37609304 DOI: 10.21203/rs.3.rs-3213777/v1 |
0.463 |
|
| 2023 |
Hansen L, McMahon M, Turner HL, Zhu X, Turner JS, Ozorowski G, Stadlbauer D, Vahokoski J, Schmitz AJ, Rizk AA, Alsoussi WB, Strohmeier S, Yu W, Choreño-Parra JA, Jiménez-Alvarez L, ... ... Ellebedy AH, et al. Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo. Immunity. PMID 37506693 DOI: 10.1016/j.immuni.2023.07.004 |
0.534 |
|
| 2023 |
Matz HC, McIntire KM, Ellebedy AH. 'Persistent germinal center responses: slow-growing trees bear the best fruits'. Current Opinion in Immunology. 83: 102332. PMID 37150126 DOI: 10.1016/j.coi.2023.102332 |
0.326 |
|
| 2023 |
Koutsakos M, Ellebedy AH. Immunological imprinting: Understanding COVID-19. Immunity. 56: 909-913. PMID 37105169 DOI: 10.1016/j.immuni.2023.04.012 |
0.452 |
|
| 2023 |
Cable J, Graham BS, Koup RA, Seder RA, Karikó K, Pardi N, Barouch DH, Sharma B, Rauch S, Nachbagauer R, Forsell MNE, Schotsaert M, Ellebedy AH, Loré K, Irvine DJ, et al. Progress in vaccine development for infectious diseases-a Keystone Symposia report. Annals of the New York Academy of Sciences. 1524: 65-86. PMID 37020354 DOI: 10.1111/nyas.14975 |
0.48 |
|
| 2023 |
Alsoussi WB, Malladi SK, Zhou JQ, Liu Z, Ying B, Kim W, Schmitz AJ, Lei T, Horvath SC, Sturtz AJ, McIntire KM, Evavold B, Han F, Scheaffer SM, Fox IF, ... ... Ellebedy AH, et al. SARS-CoV-2 Omicron boosting induces de novo B cell response in humans. Nature. PMID 37011668 DOI: 10.1038/s41586-023-06025-4 |
0.466 |
|
| 2023 |
Quinn M, Parra-Rodriguez L, Alsoussi WB, Ayres C, Klebert MK, Liu C, Suessen T, Scheaffer SM, Middleton WD, Teefey SA, Powderly WG, Diamond MS, Presti RM, Ellebedy AH, Turner JS, et al. Persons with HIV Develop Spike-Specific Lymph Node Germinal Center Responses following SARS-CoV-2 Vaccination. Journal of Immunology (Baltimore, Md. : 1950). PMID 36779802 DOI: 10.4049/jimmunol.2200920 |
0.47 |
|
| 2023 |
Cable J, Sun J, Cheon IS, Vaughan AE, Castro IA, Stein SR, López CB, Gostic KM, Openshaw PJM, Ellebedy AH, Wack A, Hutchinson E, Thomas MM, Langlois RA, Lingwood D, et al. Respiratory viruses: New frontiers-a Keystone Symposia report. Annals of the New York Academy of Sciences. PMID 36722473 DOI: 10.1111/nyas.14958 |
0.366 |
|
| 2022 |
Lin FJ, Doss AMA, Davis-Adams HG, Adams LJ, Hanson CH, VanBlargan LA, Liang CY, Chen RE, Monroy JM, Wedner HJ, Kulczycki A, Mantia TL, O'Shaughnessy CC, Raju S, Zhao FR, ... ... Ellebedy AH, et al. SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients. Frontiers in Immunology. 13: 1033770. PMID 36618402 DOI: 10.3389/fimmu.2022.1033770 |
0.525 |
|
| 2022 |
Palin AC, Alter G, Crotty S, Ellebedy AH, Lane MC, Lee FE, Locci M, Malaspina A, Mallia C, McElrath MJ, Pulendran B, Singh A, D'Souza MP. Author Correction: The persistence of memory: defining, engineering, and measuring vaccine durability. Nature Immunology. PMID 36572838 DOI: 10.1038/s41590-022-01414-9 |
0.32 |
|
| 2022 |
Stadlbauer D, McMahon M, Turner HL, Zhu X, Wan H, Carreño JM, O'Dell G, Strohmeier S, Khalil Z, Luksza M, van Bakel H, Simon V, Ellebedy AH, Wilson IA, Ward AB, et al. Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site. Nature Communications. 13: 7864. PMID 36543789 DOI: 10.1038/s41467-022-35586-7 |
0.352 |
|
| 2022 |
Palin AC, Alter G, Crotty S, Ellebedy AH, Lane MC, Lee FE, Locci M, Malaspina A, Mallia C, McElrath MJ, Pulendran B, Singh A, D'Souza MP. The persistence of memory: defining, engineering, and measuring vaccine durability. Nature Immunology. 23: 1665-1668. PMID 36456737 DOI: 10.1038/s41590-022-01359-z |
0.326 |
|
| 2022 |
Alsoussi WB, Malladi SK, Zhou JQ, Liu Z, Ying B, Kim W, Schmitz AJ, Lei T, Horvath SC, Sturtz AJ, McIntire KM, Evavold B, Han F, Scheaffer SM, Fox IF, ... ... Ellebedy AH, et al. SARS-CoV-2 Omicron boosting induces de novo B cell response in humans. Biorxiv : the Preprint Server For Biology. PMID 36172127 DOI: 10.1101/2022.09.22.509040 |
0.508 |
|
| 2022 |
Gupta SL, Mantus G, Manning KE, Ellis M, Patel M, Ciric CR, Lu A, Turner JS, O'Halloran JA, Presti RM, Joshi DJ, Ellebedy AH, Anderson EJ, Rostad CA, Suthar MS, et al. Loss of Pfizer (BNT162b2) Vaccine-Induced Antibody Responses against the SARS-CoV-2 Omicron Variant in Adolescents and Adults. Journal of Virology. e0058222. PMID 35976000 DOI: 10.1128/jvi.00582-22 |
0.497 |
|
| 2022 |
Zimmerman O, Altman Doss AM, Kaplonek P, Liang CY, VanBlargan LA, Chen RE, Monroy JM, Wedner HJ, Kulczycki A, Mantia TL, O'Shaughnessy CC, Davis-Adams HG, Bertera HL, Adams LJ, Raju S, ... ... Ellebedy AH, et al. mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes. Cell Reports. Medicine. 100653. PMID 35688161 DOI: 10.1016/j.xcrm.2022.100653 |
0.556 |
|
| 2022 |
Bamunuarachchi G, Harastani H, Rothlauf PW, Dai YN, Ellebedy A, Fremont D, Whelan SPJ, Wang D, Boon ACM. Detection of Bourbon Virus-Specific Serum Neutralizing Antibodies in Human Serum in Missouri, USA. Msphere. e0016422. PMID 35607948 DOI: 10.1128/msphere.00164-22 |
0.352 |
|
| 2022 |
Simon V, Kota V, Bloomquist RF, Hanley HB, Forgacs D, Pahwa S, Pallikkuth S, Miller LG, Schaenman J, Yeaman MR, Manthei D, Wolf J, Gaur AH, Estepp JH, Srivastava K, ... ... Ellebedy AH, et al. PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2. Msphere. e0017922. PMID 35586986 DOI: 10.1128/msphere.00179-22 |
0.485 |
|
| 2022 |
Altomare CG, Adelsberg DC, Carreno JM, Sapse IA, Amanat F, Ellebedy AH, Simon V, Krammer F, Bajic G. Structure of a Vaccine-Induced, Germline-Encoded Human Antibody Defines a Neutralizing Epitope on the SARS-CoV-2 Spike N-Terminal Domain. Mbio. e0358021. PMID 35467422 DOI: 10.1128/mbio.03580-21 |
0.514 |
|
| 2022 |
Yang MM, Taylor KE, Paez D, Carividi A, Demissie E, Pawar N, El-Qunni AA, McMorrow LE, Schriefer RE, Huang K, Kinnett B, Klebert M, Haile A, O'Halloran JA, Presti RM, ... ... Ellebedy AH, et al. Reactogenicity of the mRNA SARS-CoV-2 Vaccines Associates with Immunogenicity in Patients with Autoimmune and Inflammatory Disease. Arthritis Care & Research. PMID 35412029 DOI: 10.1002/acr.24894 |
0.441 |
|
| 2022 |
DeGrace MM, Ghedin E, Frieman MB, Krammer F, Grifoni A, Alisoltani A, Alter G, Amara RR, Baric RS, Barouch DH, Bloom JD, Bloyet LM, Bonenfant G, Boon ACM, Boritz EA, ... ... Ellebedy A, et al. Defining the risk of SARS-CoV-2 variants on immune protection. Nature. PMID 35361968 DOI: 10.1038/s41586-022-04690-5 |
0.722 |
|
| 2022 |
Teefey SA, Middleton WD, Turner JS, Ellebedy AH, Suessen T, Wallendorf M, O'Halloran JA, Presti R. SARS-CoV-2 mRNA Vaccination Causes Prolonged Increased Cortical Thickening and Vascularity in Ipsilateral Axillary Lymph Nodes. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. PMID 35257401 DOI: 10.1002/jum.15973 |
0.356 |
|
| 2022 |
Kim W, Zhou JQ, Horvath SC, Schmitz AJ, Sturtz AJ, Lei T, Liu Z, Kalaidina E, Thapa M, Alsoussi WB, Haile A, Klebert MK, Suessen T, Parra-Rodriguez L, Mudd PA, ... ... Ellebedy AH, et al. Germinal centre-driven maturation of B cell response to mRNA vaccination. Nature. PMID 35168246 DOI: 10.1038/s41586-022-04527-1 |
0.437 |
|
| 2021 |
Mudd PA, Minervina AA, Pogorelyy MV, Turner JS, Kim W, Kalaidina E, Petersen J, Schmitz AJ, Lei T, Haile A, Kirk AM, Mettelman RC, Crawford JC, Nguyen THO, Rowntree LC, ... ... Ellebedy AH, et al. SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans. Cell. PMID 35026152 DOI: 10.1016/j.cell.2021.12.026 |
0.343 |
|
| 2021 |
Laidlaw BJ, Ellebedy AH. The germinal centre B cell response to SARS-CoV-2. Nature Reviews. Immunology. 22: 7-18. PMID 34873279 DOI: 10.1038/s41577-021-00657-1 |
0.465 |
|
| 2021 |
Chen RE, Gorman MJ, Zhu DY, Carreño JM, Yuan D, VanBlargan LA, Burdess S, Lauffenburger DA, Kim W, Turner JS, Droit L, Handley SA, Chahin S, Deepak P, O'Halloran JA, ... ... Ellebedy AH, et al. Reduced antibody activity against SARS-CoV-2 B.1.617.2 Delta virus in serum of mRNA-vaccinated patients receiving Tumor Necrosis Factor-α inhibitors. Med (New York, N.Y.). PMID 34812429 DOI: 10.1016/j.medj.2021.11.004 |
0.445 |
|
| 2021 |
Kim W, Zhou JQ, Sturtz AJ, Horvath SC, Schmitz AJ, Lei T, Kalaidina E, Thapa M, Alsoussi WB, Haile A, Klebert MK, Suessen T, Parra-Rodriguez L, Mudd PA, Middleton WD, ... ... Ellebedy AH, et al. Germinal centre-driven maturation of B cell response to SARS-CoV-2 vaccination. Biorxiv : the Preprint Server For Biology. PMID 34751268 DOI: 10.1101/2021.10.31.466651 |
0.448 |
|
| 2021 |
Arunkumar GA, Bhavsar D, Li T, Strohmeier S, Chromikova V, Amanat F, Bunyatov M, Wilson PC, Ellebedy AH, Boons GJ, Simon V, de Vries RP, Krammer F. Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus. Nature Communications. 12: 6161. PMID 34697321 DOI: 10.1038/s41467-021-26409-2 |
0.475 |
|
| 2021 |
Tan J, O'Dell G, Hernandez MM, Sordillo EM, Kahn Z, Kriti D, van Bakel H, Ellebedy AH, Wilson PC, Simon V, Krammer F, McMahon M. Human anti-neuraminidase antibodies reduce airborne transmission of clinical influenza virus isolates in the guinea pig model. Journal of Virology. JVI0142121. PMID 34669506 DOI: 10.1128/JVI.01421-21 |
0.596 |
|
| 2021 |
Errico JM, Zhao H, Chen RE, Liu Z, Case JB, Ma M, Schmitz AJ, Rau MJ, Fitzpatrick JAJ, Shi PY, Diamond MS, Whelan SPJ, Ellebedy AH, Fremont DH. Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD. Cell Reports. 37: 109881. PMID 34655519 DOI: 10.1016/j.celrep.2021.109881 |
0.366 |
|
| 2021 |
Su W, Sia SF, Schmitz AJ, Bricker TL, Starr TN, Greaney AJ, Turner JS, Mohammed BM, Liu Z, Choy KT, Darling TL, Joshi A, Cheng KM, Wong AYL, Harastani HH, ... ... Ellebedy AH, et al. Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters. Mbio. e0239521. PMID 34517754 DOI: 10.1128/mBio.02395-21 |
0.428 |
|
| 2021 |
Schmitz AJ, Turner JS, Liu Z, Zhou JQ, Aziati ID, Chen RE, Joshi A, Bricker TL, Darling TL, Adelsberg DC, Altomare CG, Alsoussi WB, Case JB, VanBlargan LA, Lei T, ... ... Ellebedy AH, et al. A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants. Immunity. PMID 34464596 DOI: 10.1016/j.immuni.2021.08.013 |
0.728 |
|
| 2021 |
Deepak P, Kim W, Paley MA, Yang M, Carvidi AB, Demissie EG, El-Qunni AA, Haile A, Huang K, Kinnett B, Liebeskind MJ, Liu Z, McMorrow LE, Paez D, Pawar N, ... ... Ellebedy AH, et al. Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study. Annals of Internal Medicine. PMID 34461029 DOI: 10.7326/M21-1757 |
0.388 |
|
| 2021 |
Reynolds D, Vazquez Guillamet C, Day A, Borcherding N, Vazquez Guillamet R, Choreño-Parra JA, House SL, O'Halloran JA, Zúñiga J, Ellebedy AH, Byers DE, Mudd PA. Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19. Journal of Immunology (Baltimore, Md. : 1950). PMID 34348975 DOI: 10.4049/jimmunol.2100294 |
0.382 |
|
| 2021 |
Amanat F, Thapa M, Lei T, Ahmed SMS, Adelsberg DC, Carreño JM, Strohmeier S, Schmitz AJ, Zafar S, Zhou JQ, Rijnink W, Alshammary H, Borcherding N, Reiche AG, Srivastava K, ... ... Ellebedy AH, et al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell. PMID 34192529 DOI: 10.1016/j.cell.2021.06.005 |
0.561 |
|
| 2021 |
Turner JS, O'Halloran JA, Kalaidina E, Kim W, Schmitz AJ, Zhou JQ, Lei T, Thapa M, Chen RE, Case JB, Amanat F, Rauseo AM, Haile A, Xie X, Klebert MK, ... ... Ellebedy AH, et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature. PMID 34182569 DOI: 10.1038/s41586-021-03738-2 |
0.462 |
|
| 2021 |
Chen RE, Winkler ES, Case JB, Aziati ID, Bricker TL, Joshi A, Darling TL, Ying B, Errico JM, Shrihari S, VanBlargan LA, Xie X, Gilchuk P, Zost SJ, Droit L, ... ... Ellebedy AH, et al. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature. PMID 34153975 DOI: 10.1038/s41586-021-03720-y |
0.327 |
|
| 2021 |
Turner JS, Kim W, Kalaidina E, Goss CW, Rauseo AM, Schmitz AJ, Hansen L, Haile A, Klebert MK, Pusic I, O'Halloran JA, Presti RM, Ellebedy AH. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. PMID 34030176 DOI: 10.1038/s41586-021-03647-4 |
0.302 |
|
| 2021 |
Diamond M, Chen R, Winkler E, Case J, Aziati I, Bricker T, Joshi A, Darling T, Ying B, Errico J, Shrihari S, VanBlargan L, Xie X, Gilchuk P, Zost S, ... ... Ellebedy A, et al. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Research Square. PMID 34013259 DOI: 10.21203/rs.3.rs-448370/v1 |
0.326 |
|
| 2021 |
Deepak P, Kim W, Paley MA, Yang M, Carvidi AB, El-Qunni AA, Haile A, Huang K, Kinnett B, Liebeskind MJ, Liu Z, McMorrow LE, Paez D, Perantie DC, Schriefer RE, ... ... Ellebedy AH, et al. Glucocorticoids and B Cell Depleting Agents Substantially Impair Immunogenicity of mRNA Vaccines to SARS-CoV-2. Medrxiv : the Preprint Server For Health Sciences. PMID 33851176 DOI: 10.1101/2021.04.05.21254656 |
0.416 |
|
| 2021 |
Schmitz AJ, Turner JS, Liu Z, Aziati ID, Chen RE, Joshi A, Bricker TL, Darling TL, Adelsberg DC, Alsoussi WB, Case JB, Lei T, Thapa M, Amanat F, O'Halloran JA, ... ... Ellebedy AH, et al. A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants. Biorxiv : the Preprint Server For Biology. PMID 33791696 DOI: 10.1101/2021.03.24.436864 |
0.585 |
|
| 2021 |
Amanat F, Thapa M, Lei T, Ahmed SMS, Adelsberg DC, Carreno JM, Strohmeier S, Schmitz AJ, Zafar S, Zhou JQ, Rijnink W, Alshammary H, Borcherding N, Reiche AG, Srivastava K, ... ... Ellebedy AH, et al. The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies that target both the NTD and the RBD. Medrxiv : the Preprint Server For Health Sciences. PMID 33758878 DOI: 10.1101/2021.03.07.21253098 |
0.563 |
|
| 2021 |
Chen RE, Zhang X, Case JB, Winkler ES, Liu Y, VanBlargan LA, Liu J, Errico JM, Xie X, Suryadevara N, Gilchuk P, Zost SJ, Tahan S, Droit L, Turner JS, ... ... Ellebedy AH, et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nature Medicine. PMID 33664494 DOI: 10.1038/s41591-021-01294-w |
0.511 |
|
| 2021 |
Diamond M, Chen R, Xie X, Case J, Zhang X, VanBlargan L, Liu Y, Liu J, Errico J, Winkler E, Suryadevara N, Tahan S, Turner J, Kim W, Schmitz A, ... ... Ellebedy A, et al. SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies. Research Square. PMID 33594356 DOI: 10.21203/rs.3.rs-228079/v1 |
0.512 |
|
| 2021 |
Liu Z, VanBlargan LA, Bloyet LM, Rothlauf PW, Chen RE, Stumpf S, Zhao H, Errico JM, Theel ES, Liebeskind MJ, Alford B, Buchser WJ, Ellebedy AH, Fremont DH, Diamond MS, et al. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Cell Host & Microbe. PMID 33535027 DOI: 10.1016/j.chom.2021.01.014 |
0.363 |
|
| 2021 |
Han J, Schmitz AJ, Richey ST, Dai YN, Turner HL, Mohammed BM, Fremont DH, Ellebedy AH, Ward AB. Polyclonal epitope mapping reveals temporal dynamics and diversity of human antibody responses to H5N1 vaccination. Cell Reports. 34: 108682. PMID 33503432 DOI: 10.1016/j.celrep.2020.108682 |
0.623 |
|
| 2020 |
Liu Z, VanBlargan LA, Rothlauf PW, Bloyet LM, Chen RE, Stumpf S, Zhao H, Errico JM, Theel ES, Ellebedy AH, Fremont DH, Diamond MS, Whelan SPJ. Landscape analysis of escape variants identifies SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Biorxiv : the Preprint Server For Biology. PMID 33442690 DOI: 10.1101/2020.11.06.372037 |
0.351 |
|
| 2020 |
Ellebedy A, Turner J, Kim W, Kalaidina E, Goss C, Rauseo A, Schmitz A, Hansen L, Haile A, Klebert M, Pusic I, O'Halloran J, Presti R. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Research Square. PMID 33398264 DOI: 10.21203/rs.3.rs-132821/v1 |
0.451 |
|
| 2020 |
Mudd PA, Crawford JC, Turner JS, Souquette A, Reynolds D, Bender D, Bosanquet JP, Anand NJ, Striker DA, Martin RS, Boon ACM, House SL, Remy KE, Hotchkiss RS, Presti RM, ... ... Ellebedy AH, et al. Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm. Science Advances. PMID 33187979 DOI: 10.1126/sciadv.abe3024 |
0.326 |
|
| 2020 |
Koutsakos M, Ellebedy AH. The rise and fall of bone marrow plasma cells after influenza vaccination. Immunology and Cell Biology. PMID 33167072 DOI: 10.1111/imcb.12417 |
0.413 |
|
| 2020 |
Linderman SL, Ellebedy AH, Davis C, Eberhardt CS, Antia R, Ahmed R, Zarnitsyna VI. Influenza Immunization in the Context of Preexisting Immunity. Cold Spring Harbor Perspectives in Medicine. PMID 32988981 DOI: 10.1101/cshperspect.a040964 |
0.637 |
|
| 2020 |
Madsen A, Dai YN, McMahon M, Schmitz AJ, Turner JS, Tan J, Lei T, Alsoussi WB, Strohmeier S, Amor M, Mohammed BM, Mudd PA, Simon V, Cox RJ, Fremont DH, ... ... Ellebedy AH, et al. Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective. Immunity. PMID 32976769 DOI: 10.1016/j.immuni.2020.08.015 |
0.529 |
|
| 2020 |
McMahon M, Strohmeier S, Rajendran M, Capuano C, Ellebedy AH, Wilson PC, Krammer F. Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice. Vaccine. PMID 32943267 DOI: 10.1016/J.Vaccine.2020.08.067 |
0.629 |
|
| 2020 |
Turner JS, Zhou JQ, Han J, Schmitz AJ, Rizk AA, Alsoussi WB, Lei T, Amor M, McIntire KM, Meade P, Strohmeier S, Brent RI, Richey ST, Haile A, Yang YR, ... ... Ellebedy AH, et al. Human germinal centres engage memory and naive B cells after influenza vaccination. Nature. PMID 32866963 DOI: 10.1038/S41586-020-2711-0 |
0.664 |
|
| 2020 |
Remy KE, Mazer M, Striker DA, Ellebedy AH, Walton AH, Unsinger J, Blood TM, Mudd PA, Yi DJ, Mannion DA, Osborne DF, Martin RS, Anand NJ, Bosanquet JP, Blood J, et al. Severe immunosuppression and not a cytokine storm characterize COVID-19 infections. Jci Insight. PMID 32687484 DOI: 10.1172/Jci.Insight.140329 |
0.333 |
|
| 2020 |
Ellebedy AH, Nachbagauer R, Jackson KJL, Dai YN, Han J, Alsoussi WB, Davis CW, Stadlbauer D, Rouphael N, Chromikova V, McCausland M, Chang CY, Cortese M, Bower M, Chennareddy C, et al. Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans. Proceedings of the National Academy of Sciences of the United States of America. PMID 32661157 DOI: 10.1073/Pnas.1906613117 |
0.689 |
|
| 2020 |
Carnathan DG, Kaushik K, Ellebedy AH, Enemuo CA, Gebru EH, Dhadvai P, Rasheed MAU, Pauthner MG, Ozorowski G, Ahmed R, Burton DR, Ward AB, Silvestri G, Crotty S, Locci M. Harnessing Activin A Adjuvanticity to Promote Antibody Responses to BG505 HIV Envelope Trimers. Frontiers in Immunology. 11: 1213. PMID 32612608 DOI: 10.3389/Fimmu.2020.01213 |
0.447 |
|
| 2020 |
Alsoussi WB, Turner JS, Case JB, Zhao H, Schmitz AJ, Zhou JQ, Chen RE, Lei T, Rizk AA, McIntire KM, Winkler ES, Fox JM, Kafai NM, Thackray LB, Hassan AO, ... ... Ellebedy AH, et al. A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. Journal of Immunology (Baltimore, Md. : 1950). PMID 32591393 DOI: 10.4049/Jimmunol.2000583 |
0.434 |
|
| 2020 |
Hassan AO, Case JB, Winkler ES, Thackray LB, Kafai NM, Bailey AL, McCune BT, Fox JM, Chen RE, Alsoussi WB, Turner JS, Schmitz AJ, Lei T, Shrihari S, Keeler SP, ... ... Ellebedy AH, et al. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies. Cell. PMID 32553273 DOI: 10.1016/J.Cell.2020.06.011 |
0.458 |
|
| 2020 |
Mudd PA, Crawford JC, Turner JS, Souquette A, Reynolds D, Bender D, Bosanquet JP, Anand NJ, Striker DA, Martin RS, Boon ACM, House SL, Remy KE, Hotchkiss RS, Presti RM, ... ... Ellebedy AH, et al. Targeted Immunosuppression Distinguishes COVID-19 from Influenza in Moderate and Severe Disease. Medrxiv : the Preprint Server For Health Sciences. PMID 32511543 DOI: 10.1101/2020.05.28.20115667 |
0.381 |
|
| 2020 |
Turner JS, Lei T, Schmitz AJ, Day A, Choreño-Parra JA, Jiménez-Alvarez L, Cruz-Lagunas A, House SL, Zúñiga J, Ellebedy AH, Mudd PA. Impaired Cellular Immune Responses During the First Week of Severe Acute Influenza Infection. The Journal of Infectious Diseases. PMID 32369589 DOI: 10.1093/Infdis/Jiaa226 |
0.43 |
|
| 2020 |
Turner JS, Lei T, Schmitz AJ, Day A, Choreño-Parra JA, Jiménez-Alvarez L, Cruz-Lagunas A, House SL, Zúñiga J, Ellebedy AH, Mudd PA. Impaired Cellular Immune Responses During the First Week of Severe Acute Influenza Infection. The Journal of Infectious Diseases. PMID 32369589 DOI: 10.1093/Infdis/Jiaa226 |
0.43 |
|
| 2020 |
Bradley T, Kuraoka M, Yeh CH, Tian M, Chen H, Cain DW, Chen X, Cheng C, Ellebedy AH, Parks R, Barr M, Sutherland LL, Scearce RM, Bowman CM, Bouton-Verville H, et al. Immune checkpoint modulation enhances HIV-1 antibody induction. Nature Communications. 11: 948. PMID 32075963 DOI: 10.1038/S41467-020-14670-W |
0.451 |
|
| 2019 |
Stadlbauer D, Zhu X, McMahon M, Turner JS, Wohlbold TJ, Schmitz AJ, Strohmeier S, Yu W, Nachbagauer R, Mudd PA, Wilson IA, Ellebedy AH, Krammer F. Broadly protective human antibodies that target the active site of influenza virus neuraminidase. Science (New York, N.Y.). 366: 499-504. PMID 31649200 DOI: 10.1126/Science.Aay0678 |
0.694 |
|
| 2019 |
Davis CW, Jackson KJL, McElroy AK, Halfmann P, Huang J, Chennareddy C, Piper AE, Leung Y, Albariño CG, Crozier I, Ellebedy AH, Sidney J, Sette A, Yu T, Nielsen SCA, et al. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection. Cell. PMID 31104840 DOI: 10.1016/J.Cell.2019.04.036 |
0.536 |
|
| 2019 |
Tesini BL, Kanagaiah P, Wang J, Hahn M, Halliley JL, Chaves FA, Nguyen PQT, Nogales A, DeDiego ML, Anderson CS, Ellebedy AH, Strohmeier S, Krammer F, Yang H, Bandyopadhyay S, et al. Broad hemagglutinin-specific memory B cell expansion by seasonal influenza virus infection reflects early-life imprinting and adaptation to the infecting virus. Journal of Virology. PMID 30728266 DOI: 10.1128/Jvi.00169-19 |
0.613 |
|
| 2019 |
Mudd P, Lei T, Ellebedy A. 247EMF Impaired Human Influenza-Specific CD8+ T Cell Responses During Acute Symptomatic Seasonal Influenza Infection Annals of Emergency Medicine. 74: S97. DOI: 10.1016/j.annemergmed.2019.08.415 |
0.429 |
|
| 2018 |
Ellebedy AH. Immunizing the Immune: Can We Overcome Influenza's Most Formidable Challenge? Vaccines. 6. PMID 30248996 DOI: 10.3390/Vaccines6040068 |
0.714 |
|
| 2018 |
Nachbagauer R, Shore D, Yang H, Johnson SK, Gabbard JD, Tompkins SM, Wrammert J, Wilson PC, Stevens J, Ahmed R, Krammer F, Ellebedy AH. Broadly-reactive human monoclonal antibodies elicited following pandemic H1N1 influenza virus exposure protect mice from highly pathogenic H5N1 challenge. Journal of Virology. PMID 29899095 DOI: 10.1128/JVI.00949-18 |
0.565 |
|
| 2018 |
Nachbagauer R, Shore D, Yang H, Johnson SK, Gabbard JD, Tompkins SM, Wrammert J, Wilson PC, Stevens J, Ahmed R, Krammer F, Ellebedy AH. Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge. Journal of Virology. 92. DOI: 10.2210/Pdb6B3M/Pdb |
0.627 |
|
| 2017 |
McElroy AK, Akondy RS, Harmon JR, Ellebedy AH, Cannon D, Klena JD, Sidney J, Sette A, Mehta AK, Kraft CS, Lyon MG, Varkey JB, Ribner BS, Nichol ST, Spiropoulou CF. A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses. The Journal of Infectious Diseases. 215: 1862-1872. PMID 28863472 DOI: 10.1093/Infdis/Jix201 |
0.436 |
|
| 2017 |
Czakó R, Vogel L, Lamirande EW, Bock KW, Moore IN, Ellebedy AH, Ahmed R, Mehle A, Subbarao K. In Vivo Imaging of Influenza Virus Infection in Immunized Mice. Mbio. 8. PMID 28559489 DOI: 10.1128/Mbio.00714-17 |
0.642 |
|
| 2017 |
Holthausen DJ, Lee SH, Kumar VT, Bouvier NM, Krammer F, Ellebedy AH, Wrammert J, Lowen AC, George S, Pillai MR, Jacob J. An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses. Immunity. 46: 587-595. PMID 28423338 DOI: 10.1016/J.Immuni.2017.03.018 |
0.613 |
|
| 2016 |
Ellebedy AH, Jackson KJ, Kissick HT, Nakaya HI, Davis CW, Roskin KM, McElroy AK, Oshansky CM, Elbein R, Thomas S, Lyon GM, Spiropoulou CF, Mehta AK, Thomas PG, Boyd SD, et al. Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination. Nature Immunology. PMID 27525369 DOI: 10.1038/Ni.3533 |
0.662 |
|
| 2016 |
Zarnitsyna VI, Lavine J, Ellebedy A, Ahmed R, Antia R. Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza. Plos Pathogens. 12: e1005692. PMID 27336297 DOI: 10.1371/Journal.Ppat.1005692 |
0.663 |
|
| 2016 |
Tesini B, Halliley J, Ellebedy A, Kanagaiah P, Anderson C, Dediego M, Wang J, Zand M, Ahmed R, Krammer F, Treanor JJ, Topham D, Sangster M. Natural H3N2 influenza A Infection in Humans Expands Memory B Cells Specific for the Hemagglutinin Stalk Domain Open Forum Infectious Diseases. 3. DOI: 10.1093/Ofid/Ofw172.1742 |
0.498 |
|
| 2016 |
Ellebedy AH, Ahmed R. Antiviral Vaccines: Challenges and Advances The Vaccine Book: Second Edition. 283-310. DOI: 10.1016/B978-0-12-802174-3.00015-1 |
0.529 |
|
| 2015 |
Zarnitsyna VI, Ellebedy AH, Davis C, Jacob J, Ahmed R, Antia R. Masking of antigenic epitopes by antibodies shapes the humoral immune response to influenza. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 370. PMID 26194761 DOI: 10.1098/Rstb.2014.0248 |
0.554 |
|
| 2015 |
McElroy AK, Akondy RS, Davis CW, Ellebedy AH, Mehta AK, Kraft CS, Lyon GM, Ribner BS, Varkey J, Sidney J, Sette A, Campbell S, Ströher U, Damon I, Nichol ST, et al. Human Ebola virus infection results in substantial immune activation. Proceedings of the National Academy of Sciences of the United States of America. 112: 4719-24. PMID 25775592 DOI: 10.1073/Pnas.1502619112 |
0.474 |
|
| 2015 |
Chiu C, Ellebedy AH, Wrammert J, Ahmed R. B cell responses to influenza infection and vaccination. Current Topics in Microbiology and Immunology. 386: 381-98. PMID 25193634 DOI: 10.1007/82_2014_425 |
0.692 |
|
| 2014 |
Linderman SL, Chambers BS, Zost SJ, Parkhouse K, Li Y, Herrmann C, Ellebedy AH, Carter DM, Andrews SF, Zheng NY, Huang M, Huang Y, Strauss D, Shaz BH, Hodinka RL, et al. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. Proceedings of the National Academy of Sciences of the United States of America. 111: 15798-803. PMID 25331901 DOI: 10.1073/Pnas.1409171111 |
0.59 |
|
| 2014 |
Ellebedy AH, Krammer F, Li GM, Miller MS, Chiu C, Wrammert J, Chang CY, Davis CW, McCausland M, Elbein R, Edupuganti S, Spearman P, Andrews SF, Wilson PC, García-Sastre A, et al. Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans. Proceedings of the National Academy of Sciences of the United States of America. 111: 13133-8. PMID 25157133 DOI: 10.1073/Pnas.1414070111 |
0.677 |
|
| 2012 |
Ellebedy AH, Ahmed R. Re-engaging cross-reactive memory B cells: the influenza puzzle. Frontiers in Immunology. 3: 53. PMID 22566934 DOI: 10.3389/Fimmu.2012.00053 |
0.713 |
|
| 2011 |
Araki K, Ellebedy AH, Ahmed R. TOR in the immune system. Current Opinion in Cell Biology. 23: 707-15. PMID 21925855 DOI: 10.1016/J.Ceb.2011.08.006 |
0.335 |
|
| 2011 |
Valkenburg SA, Rutigliano JA, Ellebedy AH, Doherty PC, Thomas PG, Kedzierska K. Immunity to seasonal and pandemic influenza A viruses. Microbes and Infection / Institut Pasteur. 13: 489-501. PMID 21295153 DOI: 10.1016/J.Micinf.2011.01.007 |
0.567 |
|
| 2011 |
Ellebedy AH, Lupfer C, Ghoneim HE, DeBeauchamp J, Kanneganti TD, Webby RJ. Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59. Proceedings of the National Academy of Sciences of the United States of America. 108: 2927-32. PMID 21270336 DOI: 10.1073/Pnas.1012455108 |
0.721 |
|
| 2011 |
Ellebedy AH, Ducatez MF, Duan S, Stigger-Rosser E, Rubrum AM, Govorkova EA, Webster RG, Webby RJ. Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets. Vaccine. 29: 3335-9. PMID 20840835 DOI: 10.1016/J.Vaccine.2010.08.067 |
0.755 |
|
| 2010 |
Marcelin G, Bland HM, Negovetich NJ, Sandbulte MR, Ellebedy AH, Webb AD, Griffin YS, DeBeauchamp JL, McElhaney JE, Webby RJ. Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner. The Journal of Infectious Diseases. 202: 1634-8. PMID 20979454 DOI: 10.1086/657084 |
0.734 |
|
| 2010 |
Ellebedy AH, Fabrizio TP, Kayali G, Oguin TH, Brown SA, Rehg J, Thomas PG, Webby RJ. Contemporary seasonal influenza A (H1N1) virus infection primes for a more robust response to split inactivated pandemic influenza A (H1N1) Virus vaccination in ferrets. Clinical and Vaccine Immunology : Cvi. 17: 1998-2006. PMID 20962210 DOI: 10.1128/Cvi.00247-10 |
0.761 |
|
| 2010 |
Kim JK, Kayali G, Walker D, Forrest HL, Ellebedy AH, Griffin YS, Rubrum A, Bahgat MM, Kutkat MA, Ali MA, Aldridge JR, Negovetich NJ, Krauss S, Webby RJ, Webster RG. Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry. Proceedings of the National Academy of Sciences of the United States of America. 107: 11044-9. PMID 20534457 DOI: 10.1073/Pnas.1006419107 |
0.759 |
|
| 2010 |
Marcelin G, Bland HM, Negovetich NJ, Sandbulte MR, Ellebedy AH, Webb AD, Griffin YS, DeBeauchamp JL, McElhaney JE, Webby RJ. Inactivated season influenza vaccines increase serum antibodies to the neuraminidase of pandemic H1N1 2009 influenza virus in an age dependent manner F1000research. 1. DOI: 10.7490/F1000Research.609.1 |
0.725 |
|
| 2009 |
Ellebedy AH, Webby RJ. Influenza vaccines. Vaccine. 27: D65-8. PMID 19837290 DOI: 10.1016/j.vaccine.2009.08.038 |
0.7 |
|
| 2009 |
Thomas PG, Dash P, Aldridge JR, Ellebedy AH, Reynolds C, Funk AJ, Martin WJ, Lamkanfi M, Webby RJ, Boyd KL, Doherty PC, Kanneganti TD. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity. 30: 566-75. PMID 19362023 DOI: 10.1016/J.Immuni.2009.02.006 |
0.598 |
|
| Show low-probability matches. |